Renin biosynthesis was studied in a juxtaglomerular cell tumor. The tumoral tissue had a high renin content (180 Goldblatt Units/g of tissue), was heavily stained by immunofluorescence using human renin antiserum, and exhibited numerous characteristic secretory granules by electron microscopy. In one series of experiments, renin biosynthesis was studied in tissue slices, by following the incorporation of radiolabeled amino acids into specific immunoprecipitable renin. Time course studies showed that renin was first synthesized in a high molecular weight form, 55,000 mol wt, i.e., 10,000 mol wt higher than that of active renin, and was then converted into a 44,000-mol wt form. In a second series of experiments renin tumoral cells were cultured. Small, round, birefringent cells obtained after collagenase digestion produced renin in both primary culture and subculture media. After 5 d most of the renin found in the culture medium was inactive, but could be activated by trypsin treatment. The tumoral tissue exhibited a strong renin immunofluorescence and numerous secretory granules were observed by electron microscopy. In contrast, the reninproducing cells isolated from this tumor and grown in culture showed little renin immunofluorescence and no secretory granule could be observed. The renin-producing cells in primary culture and subculture were pulsed with radiolabeled amino acids, and immunoprecipitable radiolabeled renin was found in the culture media, thus demonstrating the actual biosynthesis […] Abstract. Renin biosynthesis was studied in a juxtaglomerular cell tumor. The tumoral tissue had a high renin content (180 Goldblatt Units/g of tissue), was heavily stained by immunofluorescence using human renin antiserum, and exhibited numerous characteristic secretory granules by electron microscopy. In one series of experiments, renin biosynthesis was studied in tissue slices, by following the incorporation of radiolabeled amino acids into specific immunoprecipitable renin. Time course studies showed that renin was first synthesized in a high molecular weight form, 55,000 mol wt, i.e., 10,000 mol wt higher than that of active renin, and was then converted into a 44,000-mol wt form. In a second series of experiments renin tumoral cells were cultured. Small, round, birefringent cells obtained after collagenase digestion produced renin in both primary culture and subculture media. After 5 d most of the renin found in the culture medium was inactive, but could be activated by trypsin treatment. The tumoral tissue exhibited a strong renin immunofluorescence and numerous secretory granules were observed by electron microscopy. In contrast, the renin-producing cells isolated from this tumor and grown in culture showed little renin immunofluorescence and no secretory granule could be observed. The renin-producing cells in primary culture and subculture
Introduction
Although the syndrome of primary reninism is an exceptional cause of hypertension it is interesting to study for many reasons. It provides the best example of a purely renin-dependent hypertension, as removal of the renin-producing tumor cures the hypertension (for review, see reference 1). It also permits extensive biochemical and morphological studies that would otherwise be extremely difficult to perform due to the scarcity of renin-producing cells in the normal kidney. For this reason, juxtaglomerular cell (JGC)' cultures have only been recently 1. Abbreviations used in this paper: AI, angiotensin I; EM, electron microscopy; FCS, fetal calf serum; GU, Goldblatt Unit, JGC, juxtaglomerular cell; MEM, minimum essential medium; PRA, plasma reain activity; RPMI, Roswell Park Memorial Institute Medium; SDS, sodium dodecyl sulfate. described by Rightsel et al. (2) in the rat. We observed a patient with hypertension due to a JGC tumor and we have previously described the complete purification of human renin (3), which was extracted from this tumor. The biochemical, enzymatic, and immunological characteristics of tumoral renin were indistinguishable from those of cadaver kidney renin. Polyclonal (3) and monoclonal (4) antibodies were raised to this renin.
Endocrine tumors also permit the study of hormone biosynthesis, and in a pioneer experiment, Steiner et al. (5) demonstrated the existence of an insulin precursor in a pancreatic insulinoma. In the case of human kidney renin no biosynthetic studies have yet been performed, due to the lack of both a sufficient number of renin-producing cells and specific renin antibodies. However, from previous renin biosynthesis studies performed in mouse submaxillary gland tissue (6) and in canine aortic smooth muscle cells, (7) renin appeared to be synthesized as a large precursor that was then converted into an active enzyme of -40,000 mol wt. The finding of another patient with a renin-producing JGC tumor offered us a unique opportunity to study renin biosynthesis in tumor slices as well as in cell culture. In the present experiments, human renin was biosynthesized as a larger molecular weight inactive precursor and then processed into a smaller active molecule.
Methods

Case report
A 25-yr-old male patient suffered from severe hypertension (240/154 mmHg) discovered during a systemic examination a few months before. There was no history of cardiovascular events. Analysis of plasma electrolytes showed an hypokalemia of 2.9 mmol/l associated with hyponatremia of 131 mmol/l and a metabolic alkalosis with a bicarbonate level of 32 mmol/l. Both plasma renin activity (PRA) in upright position (18 ng angiotensin I (AI)/ml per h, normal values < 3 ng/ml per h on a daily 60-meq sodium intake), and plasma aldosterone (800 pg/ml, normal values < 300 pg/ml) were significantly elevated. Initially no tumor was found on renal arteriography, and treatment with a combination of captopril (300 mg/d) and hydrochlorothiazide (50 mg/d) effectively normalized blood pressure for 21 mo. Subsequently the patient's hypertension became refractory to this therapy and a second renal arteriogram was performed, which demonstrated a poorly vascularized tumor in the lower pole of the right kidney. During the last hospital admission before surgery, his recumbent blood pressure was 178/126 mmHg on treatment with captopril (300 mg/d), furosemide (80 mg/d), and guanfacine (2 mg/d). On the fifth hospital day, on a low sodium diet without diuretics, and on the same antihypertensive drugs, the patient's blood pressure was 130/80 mmHg. Recumbent PRA was 30.8 ng AI/ml per h and plasma aldosterone was 153 pg/ml. After acid activation at pH 3.3 (8) , total renin was 435 ng AI/ml per h. The percentage of inactive renin was therefore 93%. The level of renin measured by direct radioimmunoassay (RIA) (8) thick) were prepared for staining with either hematoxylin-eosin-safran or Masson's trichrome and silver impregnation. Renin immunofluorescence was performed on paraffin-embedded material. After removal of paraffin with xylene, sections were passed through successive alcohol solutions and washed in phosphate-buffered saline (PBS). Indirect immunofluorescence was carried out as described previously (9) using R15 rabbit renin antiserum. The specificity of R15 rabbit antiserum was first described by Galen et al. (3) and further documented in studies dealing with the direct RIA of renin (8, 10) and with the immunohistochemistry of renin in human kidney (9) . These RENIN ASSAYS. Enzymatic assay. The concentration of active renin was assayed by its enzymatic activity on 0.5 MM renin-free human angiotensinogen prepared as already described (8) . AI produced during the 30-min incubation was measured by RIA (12 Direct renin RIA. A rapid direct renin RIA was established in order to follow the daily renin production in cultures. The modification of the previously described method (10) consisted of a decrease in the incubation time of renin with antiserum (2 h instead of 48 h) and an increase in the amount of both renin and antiserum. The modification made it possible to obtain renin measurements within 6 h. RENIN CHARACTERIZATION. Renin produced in cell cultures was characterized by the effect of pH on its reaction with human angiotensinogen, and by the effect of RI5 antiserum. These effects were compared with those of standard human renal renin (Medical Research Council, London, England). The optimum pH of trypsin-activated renin was determined by incubation with 0.5 MM human angiotensinogen in citratephosphate buffer at various pH, from 4.5 to 7.0. The ability of renin antiserum to inhibit the enzymatic activity of 25 M Goldblatt Units (GU) of trypsin-activated renin was tested by incubating the renin and antiserum together for 24 h at 4VC and then measuring the remaining activity. The high immunospecificity of this human renin antibody has already been demonstrated, by adsorption of R15 antiserum with pure human renin, in both immunofluorescence staining (9) and in renin biosynthetic experiments (14) . ANGIOTENSINOGEN ASSAY. Angiotensinogen was measured by direct RIA (15) . The sensitivity of this method is 200 pg/assay tube.
CONVERTING ENZYME ASSAYS. Converting enzyme was measured by both the spectrophotometric assay of Cushman and Cheung (16) and by a direct RIA (17) . The sensitivity of the RIA was 1.5 ng/ assay tube. specific activity of 1,095 and 50 Ci/mmol, respectively. Incubation was performed at 37°C with horizontal agitation under 5% CO2 in 02. The pulse experiments lasted for 20 min or 4 h, followed by a chase of 4 or 6 h, respectively. The chase was realized by addition of 2 Umol of nonlabeled methionine and leucine. In a separate flask the pulse experiment was extended up to 10 h. The reaction was stopped by removing the medium. Tissue was homogenized with a Teflon glass homogenizer using 1 ml buffer A/0. 1 g tissue. The extracts were centrifuged 30 min at 20,000 g. The supernatant was dialyzed overnight against buffer A and stored at -20°C.
Cell cultures. On day 12 of the primary culture of flask C5, and day 17 of the secondary culture obtained from C5 cells, the medium was replaced by serum-free RPMI culture medium. 20 h later the medium was changed and cells were incubated in methionine-and leucine-free Eagle MEM (Gibco Laboratories), supplemented with 75 MCi of [35S]methionine/ml (CEA) and 75 ,Ci of [3H]leucine/ml (CEA) with a specific activity of 1,070 and 105 Ci/mmol, respectively. Incubations were continued for 48 h and an aliquot ofeach supernatant was removed at various times. In parallel experiments a 1,000-fold excess of nonradioactive methionine and leucine was added after 1, 3, 6, 10, 24, and 48 h. The medium was then dialyzed overnight against buffer A, centrifuged, and stored at -20°C. The cells were scrapped offthe flask with a rubber policeman and washed three times with 2 ml buffer A. Cells were then suspended in 0.5 ml of the same buffer, sonicated for 15 s and stored at -20°C. Simultaneous measurements of radioactive-labeled proteins and renin were performed both in the medium and in the cell sonicate. In a separate flask C5, the incorporation of labeled amino acids was performed in the presence of 10-5 M cycloheximide. After a 24-h incubation the reaction was stopped as described above.
DETERMINATION OF THE RADIOACTIVE-LABELED PROTEINS.
The incorporation of ["S]methionine and [3H]leucine into proteins in incubation media or cell extracts was measured in 5-,Ml samples that were precipitated with 100 Ml 10% trichloracetic acid in the presence of 100 Ml albumin (1 mg/ml) as a carrier protein. The precipitate was washed four times with 1 ml 5% trichloracetic acid, dissolved in 500 Ml 0.1 M NaOH, and counted in a Packard tricarb liquid scintillation spectrometer using Picofluor 15 (Packard Instrument Co., Inc., Downers Grove, IL) as scintillation cocktail. Correction was made for the overlap of 35S in the 3H-channel. PURIFICATION and 90% of that contained in 25 Ml dialyzed culture medium or cell extract. Radioactivity was quantitated as described above.
Method 2. Affinity chromatography on antihuman renin monoclonal antibody-Sepharose was performed using a new monoclonal antibody directed against human renin, 1A12 F37, obtained using the method already described (4). IA12 F37 differs from the first monoclonal antibody, F15, by its higher affinity for human renin (association constant 109 M-'). Half-maximal binding to iodinated renin is obtained at a concentration of 5 X 10-10 M. The antibody is specific of primate renin and does not bind renin of other species nor other acid proteases: the binding of iodinated renin to the antibody is displaced by 5 ng human renin whereas up to 5 ug mouse or hog renin, hog pepsin, or human cathepsin D do not modify this binding. The specificity of IA12 F37 for human renin was further documented by its ability to exclusively stain JGC ofhuman kidney, both in indirect fluorescence and peroxydaseantiperoxydase technique. The purified IgG fraction of the antibody was coupled to Sepharose 4-B according to March et al. (18) using 10 mg IgG/ml gel. The immunoadsorbant obtained was characterized by its ability to bind human active and inactive renin at pH 7.5. Active renin was obtained from a kidney extract. The source of inactive renin was the supernatant of chorionic cell culture that contains renin under a 95% inactive form (14) . Both forms of renin were eluted in 6 M guanidine. Three different types of extracts were purified on 0.5 ml immunoadsorbant: (a) extracts from tumor slices (450 Ml); (b) culture medium corresponding to 48 h of biosynthesis (10 ml); and (c) 500 Ml of cold medium from C5 flask, supplemented with -50,000 cpm iodinated pure human renin. This preparation was run on the gel as a control for the elution pattern of both active (iodinated) and inactive (culture medium) renin. Renin containing fractions were dialyzed and lyophylized, and aliquots of the fractions were analyzed by sodium dodecyl sulfate (SDS) gel electrophoresis according to Laemmli (19) with 10% acrylamide. Protein standards for molecular weight determination were obtained from Bio-rad Laboratories (Richmond, CA). Labeled proteins were detected by fluorography (EN3 HANCE, New England Nuclear, Boston, MA) using Kodak X-ray film NS2T (Eastman Kodak Co., Rochester, NY). Autoradiograms were either revealed or scanned using cellomatic equipment (Sebia, Paris, France).
Results
Characterization of the tumor MORPHOLOGY. The tumor weighed 14 g and was delimited by a fibrous capsule.
Light microscopy. The tumor consisted of polygonal cells arranged in cords from one to several cells thick. Tumor cells showed large vesicular nuclei with occasional nuclear polymorphism and finely granular cytoplasm. On impregnation with silver stain, cells appeared to be surrounded by a basement membrane, which was particularly evident in close proximity to small muscular arteries. In all areas the tumor was richly vascularized, with ectasic vascular profiles in some areas. Small arteries showed intimal thickening and hyalinosis.
Renin immunofluorescence. The cytoplasm of most tumor cells was fluorescent (Fig. 1 B) dominant cells obtained in all five series of flasks (Fig. 2 B) and were the only cell types observed in flasks C4 and C5. These cells showed a uniform morphology. In flasks C4 and C5 mitosis was observed only between days 8 and 12 of primary culture. During the following days, the cells appeared to be in a resting phase. By immunofluorescence, carried out after 20 d ofprimary culture, some of these small round cells were diffusely stained with renin antiserum; in some cells, the specific immunofluorescence was more marked (Fig. 1 D) . By 24 (Fig. 3) . Enzymatic and immunoreactive renin was found in the medium of primary cultures up to day 27 and in secondary and tertiary culture media. After three passages, no renin was detected, whichever method was used (Table I) .
On the first day of culture, 45% of renin was present in an active form but this percentage rapidly decreased with increased duration of culture (Fig. 4) . By day 10, <5% of renin was active. As for the tissue, measurement of total renin by direct RIA or by assay of the amount of AI produced after trypsin activation gave similar results when expressed in GU (r = 0.96 for n = 24).
Renin present in the culture medium showed enzymatic and immunological properties similar to those of MRC human renin: trypsin-activated renin from the culture medium had the same optimum pH curve with human angiotensinogen (pH 5.7) as MRC renin (results not shown); the enzymatic activity of both MRC human renal renin and renin from cell culture were fully inhibited by renin antiserum at a 1/10,000 dilution and 50% inhibition was obtained using a 120,000-fold dilution of the antiserum. It was verified that the culture medium containing FCS itself did not generate Al during the 30-min incubation and did not displace renin in the direct RIA. Finally, pure human renin and renin from the cultures exhibited parallel curves when assayed in serial dilutions in the direct renin RIA (Fig. 5 ).
Angiotensinogen and converting enzyme were measured in the media of flask C5 at days 2, 6, 19, 22, and 23 of primary culture and in control incubation medium containing 10% FCS. Assay of converting enzyme by the enzymatic method revealed the presence of a low concentration of converting enzyme (1.00 to 1.44 mU/ml) in the culture medium, with similar levels being obtained in control medium (1.69 mU/ml). Converting enzyme measured by the direct RIA specific for the human enzyme was undetectable throughout the culture as well as in the control medium. It is therefore assumed that converting enzyme activity detected by the enzymatic assay was due to the presence of the enzyme in FCS, and that no human converting enzyme was secreted by the cells. By direct RIA specific for human substrate, angiotensinogen was undetectable in the medium throughout the culture as well as in the control medium. Therefore, it is assumed that these renin producing cells do not release angiotensinogen into the medium.
Biosynthesis of radiolabeled renin
BIOSYNTHESIS EXPERIMENTS ON CELL CULTURES. Radioactive amino-acid incorporation into total protein and renin was studied in flask C5 at day 13 of primary culture and at day 18 of subculture. Fig. 6 shows the time course ofthe distribution of radiolabeled proteins and renin between the cell extracts and the culture medium. Renin, like most newly biosynthesized proteins, was not stored in the cells but was rapidly secreted into the medium. Cycloheximide abolished renin biosynthesis during the 24 h of the study. Since renin was not stored inside the cell, further studies were carried out on renin secreted into the medium for up to 48 h. Renin biosynthesis was linear from 6 to 48 h. From these experiments it was calculated that renin represented 3-10% of the total biosynthesized proteins secreted into the culture medium. When biosynthesis studies were performed again, on day 18 of secondary culture, renin was still radiolabeled but represented only 1-2% of the biosynthesized proteins in the medium. The radioactive labeled renin was characterized in SDS-gel electrophoresis after purification by immunoaffinity chromatography on an antirenin IA12 F37 antibody-Sepharose column (Fig. 7 A) . Renin exhibited a single band with an apparent molecular weight of 55,000. In the same conditions, pure active human renin had an apparent molecular weight of 44,000. No 44,000-mol wt renin could be detected in any of the cell culture media assayed. Using the same antibody-Sepharose column, both iodinated pure human renin and immunoreactive renin from the culture medium were eluted in the same guanidine fraction (Fig. 7 B) .
BIOSYNTHESIS EXPERIMENTS ON TUMOR SLICES.
Labeled renin was also obtained in the experiment performed on the tumor slices and was purified by the same affinity gel, specific for human renin. Purified fractions were analyzed on SDS-gel electrophoresis. The patterns of the gels after autoradiography and scanning are given in Fig. 8 . No radioactive material could be detected on the extract corresponding to 20-min incorporation with [35SJmethionine and [3H]leucine. In contrast, the extract corresponding to a 4-h pulse was characterized by the presence of a major band of 55,000 and a minor band of 44,000 mol wt, while the extract corresponding to a 4-h pulse + 6-h chase exhibited a minor band of 55,000 and a major band of 44,000 mol wt.
Discussion
This new case of JGC tumor shows a number of similarities with most of the previously described cases. The renin content of the tumor was -1,000 times higher than that found in a normal human kidney (20) . By light microscopy and immunofluorescent staining, these tumoral cells possessed the structural characteristics and the immunochemical properties of epitheloid cells from the JGC apparatus. Almost no immunofluorescence was found in the cytoplasm of the myocytelike cells surrounding the vessels, whereas granular and diffuse immunofluorescence was observed in the renin-producing cells. Ultrastructural studies of these cells showed the presence of two types of granule, specific rhomboidal protogranules with a paracrystalline structure and spherical dense renin granules. Hours of incorporation This renin tumor offered a unique opportunity to culture and subculture the human JGC. Such studies are extremely difficult to perform in normal kidney due to the scarcity of these cells. The availability of a rapid direct renin RIA greatly facilitated the detection of renin production in the culture medium; results could be obtained within 6 h. The high specificity of the polyclonal antibody raised to human renin prevented any interference with renin in FCS. Since the increase in the enzymatic activity of renin after trypsin treatment in vitro, in plasma, amniotic fluid (8) , and chorionic cells (14) is not accompanied by a change in immunodetectable renin, it is concluded that our antibody, as others (21) recognizes both the active and inactive forms of the enzyme. The results of the enzymatic assay of trypsin-activated renin are identical to those with the RIA (r = 0.96). This identity has also been confirmed by Craven et al. (22) with chorionic renin, using our antibody.
Conn et al. (23) have previously cultured renin cells from a JGC tumor and were able to maintain a renin production up to 500 h. In the present study, two types of cell preparations were tried and only collagenase treatment produced cells that synthesized renin. The small round cells observed after long exposure to collagenase are most likely to be the renin-producing cells since biosynthesis of radiolabeled renin was observed in the flasks that contained only this cell type. No firm conclusion can be drawn on the ability of the smooth musclelike cells to produce renin, since no culture flask contained exclusively this type of cells. Although it is difficult to compare the morphology of cells in culture with that observed in tissue, the morphology of the cultured "smooth musclelike" cells was close to that of the myocytelike cells of the tumor that failed to exhibit immunofluorescence with renin antiserum. Finally, the round renin-producing cells became elongated after 2-3 passages and at the same time lost their ability to produce renin. This dedifferentiation ofrenin-producing cells is expected as JGC tumors are nonmalignant tumors.
The Al-producing enzyme released by the cells in culture was characterized as renin by its ability to hydrolyze human angiotensinogen, its pH optimum, the inhibition ofits enzymatic activity by renin antiserum at the same dilution as standard human renin, and its immunological identity with standard renal and pure tumoral renin (10) demonstrated by the parallelism of the dilution curves in our direct RIA. During the first days of culture, 45% of renin released was in active form, but the percentage of active renin in the medium decreased with the duration of culture and by day 10 essentially all renin in the medium was inactive. The relatively high levels of active renin in the medium initially may correspond, at least in part, to the release ofthe enzyme previously stored within the secretory granules ofthe tumor, as the tumor itselfcontains predominantly active renin. Similarly, an initial large release of active renin into the culture medium was found by Conn et al. (23) . After this sharp decrease in renin release, a stable renin concentration was found in the culture medium, both in this study and in the report of Conn. However, Conn may have underestimated renin concentration since only active renin was measured. This fairly stable renin concentration in the culture medium suggests that the cultured cells are actually synthesizing renin. Definitive proof of this synthesis was provided by the incorporation of labeled amino acids into the renin molecule in both primary and secondary culture. The fact that newly synthesized renin is rapidly released in the culture medium and not stored in the cell is consistent with the low level of immunofluorescence staining in the cultured cells and with the absence ofgranules by electron microscope.
The inactive renin found in the primary and secondary culture media was activated by trypsin, as with plasma or amniotic inactive renin. After activation, renin had the same properties as fully active renin. Inactive renin (after 24 and 48 h of incorporation) was biosynthesized as a single molecule of 55,000 mol wt, larger than the fully active pure human renin molecule (44,000 mol wt) (14) . By contrast, in the biosynthesis experiments performed on the tumor slices two forms of labeled renin were obtained, 55,000 and 44,000 mol wt, and the pulse chase experiment indicated that the 55,000-mol wt renin was converted into 44,000-mol wt renin. Using human chorionic cell cultures, which produced almost exclusively inactive renin, we also found Elution volume (ml) mol wt) and processed into active renin (38,000 mol wt) after release ofa prosequence of46-amino acid length (24) . Murakami (25) has recently shown that in man renal preprorenin synthetized in a cell-free reticulocyte system has a molecular weight of 45,000. The apparent increase in molecular weight of the presently described 55,000-mol wt prorenin can be explained by the fact that human renin, but contrast with mouse renin, is glycosylated (3, 26) . Glycosylation is well known to be responsible for an apparent increase of protein molecular weight on SDS-gel electrophoresis. 55,000-mol wt glycosylated prorenin is further processed into 44,000-mol wt glycosylated renin. A comparative schema for the maturation of mouse and human renin is proposed in Fig. 9 . Molecular cloning and study of the structure of human renin cDNA will most likely confirm this model of processing.
In this study, the cultured cells did not release angiotensinogen or converting enzyme into the medium: these components of the renin-angiotensin system were not detected by enzymatic or direct RIA. This is in contrast with the report of _ 1. 5 - surements performed on the tumor homogenate. The biosynthesis experiments have also shown the presence of two forms of renin (55,000 and 44,000 mol wt) in the tumor and the conversion ofthe 55,000-mol wt form (prorenin) into the 44,000-mol wt form (active renin). In this tissue, renin is found in secretory granules and morphological data suggest that the mature granules were derived from the protogranules. In the kidney, also, the same two types of renin granules have been described: sharply angulated granules (identical to our protogranules) indicative of a high rate of renin synthesis and lobulated granules (identical to our mature granules) (27) . By (28) and in cell culture (14) . This two-pathway model, which implies that mature granules contain mainly active renin, involves several assumptions that will have to be proven. The (24) and from the biosynthetic pathway described by Catanzaro et al. (6) . Human preprorenin was obtained by Murakami in an acellular translation system (25) . 55,000-and 44,000-mol wt renin were obtained in the JGC tumor. m, Prefragment; m, profragment; cD, active renin; and X, site of glycosylation.
exact nature of renin in the renin granules is not known, since some authors found inactive renin in purified rat renin granules (29) whereas others found mainly active renin in granules from dog (30) cretion in the medium of either ACTH precursor or mature ACTH (33) .
